Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology

Tumori

Volumn 94, Issue 1, 2008, Pages 52-58

  Galimberti, Viviana ^a,c   Leonardi, Maria Cristina ^a   Rotmensz, Nicole ^a   Botteri, Edoardo ^a   Iodice, Simona ^a   Sagona, Andrea ^a   Sahium, Rafaela Cecilio ^a   Bassani, Gulliermo ^a   Berrettini, Anastasio ^a   Monti, Simonetta ^a   Gentilini, Oreste ^a   Sangalli, Claudia ^a   Luini, Alberto ^a   Orecchia, Roberto ^a,b   Veronesi, Umberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Department of Medicine   (Italy)

Author keywords

Axillary dissection; Axillary metastases; Axillary radiotherapy; Breast cancer; Supraclavicular radiotherapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; PRACTICE GUIDELINE; PROGNOSIS; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; TREATMENT INDICATION;

EID: 41749085926     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400110     Document Type: Article

References (30)

1. Galimberti V: International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol, 24: 210-211, 2006.
2. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Coldman AJ, Olivotto IA: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med, 337: 956-962, 1997.
3. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med, 337: 949-955, 1997.
4. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT: Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group (DBCG) 82c randomised trial. Lancet, 353: 1641-1648, 1999.
5. Pierce LJ, Glatstein E: Postmastectomy radiotherapy in the management of operable breast cancer. Cancer, 74: 477-485, 1994.
6. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med, 333: 1444-1455, 1995.
7. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet, 355: 1757-1770, 2000.
8. Taylor ME, Haffty BG, Shank BM, Halberg FE, Martinez AA, McCormick B, McNeese MD, Mendenhall NP, Mitchell SE, Rabinovitch RA, Solin LJ, Singletary SE, Leibel S, Recht A: Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. Radiology, 215: 1153-1170, 2000.
9. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D: National Institutes of Health Consensus Development Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst, 93: 979-989, 2001.
10. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML: Does locoregional radiotherapy improve survival in breast cancer? A meta-analysis. J Clin Oncol, 18: 1220-1229, 2000.
11. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG, American Society of Clinical Oncology: Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol, 19: 1539-1569, 2001.
12. Truong PT, Olivotto IA, Whelan TJ, Levine M, Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional postmastectomy radiotherapy. CMAJ, 170: 1263-1273, 2004.
13. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst, 97: 116-126, 2005.
14. Danish Breast Cancer Cooperative Group, Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J: Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82b and c randomized studies. J Clin Oncol, 24: 2268-2275, 2006.
15. Whelan T, Levine M: More evidence that locoregional radiation therapy improves survival: what should we do? J Natl Cancer Inst, 97: 82-84, 2005.
16. Kingsmore DB, Hole DJ, Gillis CR, George WD: Axillary recurrence in breast cancer. Eur J Oncol, 31: 226-231, 2005.
17. Axelsson CK, Mouridsen HT, Zedeler K: Axillary dissection for level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer, 28: 1415-1418, 1992.
18. Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD: Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys, 63: 1508-1513, 2005.
19. Evron E, Barzily L, Rakowsky E, Ben-Baruch N, Sulkes J, Rizel S, Fenig E: Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension. IMAJ, 7: 439-442, 2005.
20. Livi L, Paiar F, Simontacchi G, Barca R, Detti B, Fondelli S, Bastiani P, Santini R, Scotti V, Bianchi S, Cataliotti L, Mungai V, Biti G: Locoregional failure pattern after lumpectomy and breast irradiation in 4185 patients with T1 and T2 breast cancer. Implications for nodal irradiation. Acta Oncol, 45: 564-570, 2006.
21. Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, Falkson G, Falkson HC, Taylor SG, Tormey DC: Loco-regional failure 10 years following mastectomy and adjuvant chemotherapy with or without tamoxifen without radiation. Experience of the Eastern Cooperative Oncology Group. J Clin Oncol, 17: 1689-1700, 1999.
22. Stranzl H, Peintinger F, Ofner P, Prettenhofer U, Mayer R, Hackl A: Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Strahlenther Onkol, 180: 623-628, 2004.
23. Hellman S: Stopping metastases at their source. N Engl J Med, 337: 996-997, 1997.
24. Koscielny S, Tubiana M: The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys, 43: 11-24, 1999.
25. Arriagada R, Lê MG: Adjuvant radiotherapy in breast cancer. The treatment of lymph node areas. Acta Oncol, 39: 295-305, 2000.
26. Clarke M, Collins R, Darby S, Davies C, Elphinstone R Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet, 366: 2087-2106, 2005.
27. Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N: Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or with out tamoxifen and without radiotherapy: results from five national surgical adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol, 22: 4247-4254, 2004.
28. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S: Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol, 13: 2869-2878, 1995.
29. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol, 12: 447-453, 1994.
30. Cuzick J, Stewart H, Peto R, Fisher B, Kaae S, Johansen H, Lythgoe JP, Prescott RJ: Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep, 71: 15-29, 1987.